This white paper provides an updated global assessment of 257 genomic initiatives, analyzing trends in funding, geography, data types, and applications. It highlights dramatic reductions in sequencing costs, the rise of multi-omics research, and the expanding role of genomics in drug development, personalized medicine, and global health. The paper identifies disparities in population representation and growing reliance on public-private partnerships to sustain initiatives. It also addresses challenges related to data governance, ethics, and long-term funding. The paper concludes that equitable collaboration and robust infrastructure are critical to unlocking genomics’ full potential worldwide.

Join for free to read